MedTrace Logo

Efficacy and Safety of XEN63 Gel Implant

NCT06844240 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2025-02-25

No results posted yet for this study

Summary

The study is prospective, observational, multicenter and has the aim of evaluating the efficacy and safety of the XEN63 implant in patients with primary or secondary glaucoma who require surgery in association or not with cataract surgery, for IOP not controlled by medical therapy, disease progression or intolerance to topical therapy, comparing IOP values before and 24 months after implantation.

Conditions

Sponsors & Collaborators

  • Mario Stirpe

    lead OTHER

Principal Investigators

  • Francesco Oddone, MD, PhD · IRCCS-Fondazione GB Bietti

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-28
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06844240 on ClinicalTrials.gov